Cited by 15Artificial Intelligence in Healthcare and EducationAI in cancer detectionArtificial Intelligence in Healthcare

Implementation of Artificial Intelligence Approaches in Oncology Clinical Trials: A Systematic Review

Saady, Marwa, Eissa, Mahmoud, Yacoub, Ahmed S., Hamed, Ahmed B., Azzazy, Hassan Mohamed El-Said·2025·Artificial Intelligence in Medicine

Abstract

INTRODUCTION There is a growing interest in leveraging artificial intelligence (AI) technologies to enhance various aspects of clinical trials. The goal of this systematic review is to assess the impact of implementing AI approaches on different aspects of oncology clinical trials. METHODS Pertinent keywords were used to find relevant articles published in PubMed, Scopus, and Google Scholar databases, which described the clinical application of AI approaches. A quality evaluation utilizing a customized checklist specifically adapted was conducted. This study is registered with PROSPERO (CRD42024537153). RESULTS Out of the identified 2833 studies, 72 studies satisfied the inclusion criteria. Clinical Trial Enrollment & Eligibility were among the most commonly studied clinical trial aspects with 30 papers. The prediction of outcomes was covered in 25 studies of which 15 addressed the prediction of patients' survival and 10 addressed the prediction of drug outcomes. The trial design was studied in 10 articles. Three studies addressed each of the personalized treatments and decision-making, while one addressed data management. The results demonstrate using AI in cancer clinical trials has the potential to increase clinical trial enrollment, predict clinical outcomes, improve trial design, enhance personalized treatments, and increase concordance in decision-making. Additionally, automating some areas and tasks, clinical trials were made more efficient, and human error was minimized. Nevertheless, concerns and restrictions related to the application of AI in clinical studies are also noted. CONCLUSION AI tools have the potential to revolutionize the design, enrollment rate, and outcome prediction of oncology clinical trials.

Integrity signals

Registry

Crossref · 10.1016/j.artmed.2025.103066

Cites

140 of 140 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AI systems for clinical trial operations can parse biomarker requirements, prior therapies, and performance status from EHRs, identify potentially eligible patients, and flag candidates for screening.

    “Systems parse biomarker requirements, prior therapies, and performance status from EHRs, identify potentially eligible patients, and flag candidates for screening [56,57,58,59,60,61,62].”

Cites

Flagged first, then by citations

4 of the 144 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Saady, M., Eissa, M., Yacoub, A. S., Hamed, A. B., & Azzazy, H. M. E.-S.
Affiliations
  • American University in Cairo (EG)
  • Salisbury District Hospital (GB)
  • The University of Texas at Arlington (US)
  • Future University in Egypt (EG)
Corresponding author
Azzazy, Hassan Mohamed El-Said
Venue
Artificial Intelligence in Medicine
Publisher
Elsevier BV
Published
2025-03
Volume
161
Pages
103066
ISSN
0933-3657 (ISSN-L)
OpenAlex
W4406549900
Cited by
15
References
144
Citations by year
2026: 7 · 2025: 8
FWCI
0.89
Type
journal article
Language
en
Open access
closed
Locations
  • Artificial Intelligence in Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
The American University in Cairo
Topics
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
Keywords
artificial intelligence, cancer clinical trials, clinical trial recruitment, eligibility determination, outcome prediction, survival prediction, drug response prediction, trial design, personalized treatment, clinical decision-making, clinical data management
MeSH terms
Artificial Intelligence, Clinical Trials as Topic, Humans, Medical Oncology, Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review